Clinical Trial Update: Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing aliskiren plus hydrochlorothiazide versus aliskiren alone in patients with metabolic syndrome and stage 2 systolic hypertension; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• Aliskiren (Aliskiren)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-01-12